Fleury
Instituto Fleury SA, operating as Grupo Fleury, is a Brazilian diagnostic medicine and healthcare services enterprise. The company provides clinical laboratory testing, diagnostic imaging, genomic sequencing, preventive health check-ups, and outpatient medical services through diagnostic centers under brands including Fleury, a+ Medicina Diagnostica, and Pardini. Main revenue drivers comprise diagnostic laboratory testing fees, MRI and CT imaging service billings, and specialized genomic test charges paid by health insurance plans and private patients. Grupo Fleury serves individual private patients, commercial health insurance providers, and hospital networks across major Brazilian states. The company holds a market-leading position in Brazil for premium diagnostic medicine and specialized laboratory services. Headquartered in Sao Paulo, Brazil, Instituto Fleury SA is listed on the B3 exchange.
5 of the funds FundTelligence covers report a position in Fleury.
- Sector
- Health Care
- Country
- Brazil
- Funds holding it
- 5
Funds holding Fleury
- Nordea Emerging Markets — Nordea Funds · 0.78 % (full portfolio disclosed, September 2026)
- Nordea Emerging Market Equities — Nordea Funds · 0.71 % (full portfolio disclosed, September 2026)
- SEB Emerging Marketsfond — SEB · 0.06 % (full portfolio disclosed, June 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.01 % (full portfolio disclosed, October 2026)
- Handelsbanken Brasilien Tema — Handelsbanken · 2.7 % (full portfolio disclosed, December 2024)